3Willemes PH, Oosterhuis JW, Aalders JG, et al. Malignant struma ovarii treated by ovariectomy, thyroidectomy and 131I administration[J].Cancer, 1987, 60(2): 178-182.
4Bhattacharya, U., Daouk, H., and Welker, M, The world price of earnings opacity [J]. The Accounting Review, 2003,78:641-678.
5Checrallah A, Medlej R, Saade C, et al. Malignant struma ovarii: an unusual presentation[J].Thyroid, 2001, 11(9):889-892.
6Christopher P, Desimone MD, Subodh M, et al. Malignant struma ovari: a case report and analysis of cases reportcd in the literature with focus on survival and 131I therapy[J].Gynecol Oncol, 2003, 89(3):543-548.
7Chechia A, Koubaa A, Makhlouf T, et al. Struma ovarii. Report of a malignant and a benign case[J].Tunis Med, 2002, 80(1):53-56.
9Abbott, L. J, S. Parker, andG. F. Peters. 2000. The effectiveness of Blue Ribbon Committee Recommendations in mitigasting financial misstatements: an empirical study, www.ssm.com
10Beasley, Mark. S. 1996. An Empirical Analysis of the Relation Between Board of Director Composition and Financial Statement Fraud. The Accounting Review, October: 443-465.
